V019-4011 Screening compound: 1-[1-(2-phenylethyl)-1H-1,3-benzodiazol-2-yl]-N-[(pyridin-4-yl)methyl]piperidine-4-carboxamide

Chemical Structure Depiction of ChemDiv screening compound V019-4011
1-[1-(2-phenylethyl)-1H-1,3-benzodiazol-2-yl]-N-[(pyridin-4-yl)methyl]piperidine-4-carboxamide

Available from 1 mg

Formats:

Glass Vials (4ml Glass Vials VWR #97047-678)
96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Check Price and Availability

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-4011

Molecular Formula

C₂₇H₂₉N₅O (C27 H29 N5 O)

Compound Name

1-[1-(2-phenylethyl)-1H-1,3-benzodiazol-2-yl]-N-[(pyridin-4-yl)methyl]piperidine-4-carboxamide

IUPAC name

1-[1-(2-phenylethyl)-1H-13-benzodiazol-2-yl]-N-[(pyridin-4-yl)methyl]piperidine-4-carboxamide

SMILES

O=C(C(CC1)CCN1c1nc(cccc2)c2n1CCc1ccccc1)NCc1ccncc1

InChI

InChI=1S/C27H29N5O/c33-26(29-20-22-10-15-28-16-11-22)23-13-17-31(18-14-23)27-30-24-8-4-5-9-25(24)32(27)19-12-21-6-2-1-3-7-21/h1-11,15-16,23H,12-14,17-20H2,(H,29,33)

InChI Key

HKDOJHIUVLQHOW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19970824

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

439.56

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

Partition Coefficient, logP

3.671

Distribution Coefficient, logD

3.667

Water Solubility, LogSw

-3.69

Polar Surface Area

46.980

Acid Dissociation Constant (pK_a)

13.00

Base Dissociation Constant (pK_b)

5.29

Number of Chiral Centers

0.00

Percent sp³ carbon bonding

29.60

V019-4011 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

CNS Targets (44014 compounds)

CORONAVIRUS Library (20774 compounds)

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Nucleic Acid Ligands (8311 compounds)

PI3K-Targeted Library (17255 compounds)

PLpro Library (6343 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Ion Channels Focused Library (26372 compounds)

Included in 1.7M Stock Database

Therapeutical areas:

Antiviral
Infections
Immune system
Nervous system
Antiviral
Infections
Immune system
Musculoskeletal
Respiratory tract
Nervous system
Congenital
Skin
Metabolic
Endocrine
Hemic and lymphatic
Cardiovascular
Infections
Cancer
Musculoskeletal
Nervous system
Hemic and lymphatic
Immune system
Cancer
Digestive system
Respiratory tract
Otorhinolaryngologic
Male
Female
Hemic and lymphatic
Skin
Antiviral
Infections
Immune system
Infections
Cancer
Musculoskeletal
Digestive system
Respiratory tract
Male
Female
Cardiovascular
Skin
Metabolic
Immune system
Nervous system
Cardiovascular

Targets:

GPCR
Kinases
Proteases
Ion Channels

Mechanism of action:

Receptor's ligands

References: we are preparing a list of scientific research reports with V019-4011 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-4011?
Check Price and Availability of V019-4011, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.

What is the minimum amount of V019-4011 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.

Delivery options for V019-4011
ChemDiv sends parcels with Express services (UPS, WC).

1–2 days for small orders
2–4 weeks for large selections

Delivery formats for V019-4011

0.5–50 mg of dry powder sample in single glass vials, custom vials
DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-4011 available by request